POLICY TITLE: Guidelines for Development of Regulatory Binders/Files

Policy #:  DM-2

 

Version #:  1

Next Review Date:  12/04

Approved Version #:  1   Date:  12/02

Interval Period:  Biannual

POLICY STATEMENT:  A regulatory file/binder will be kept for all clinical trials in each branch/research
unit. The system for maintenance of these files will be developed at the branch or research unit level, but will meet the standards set forth in the Center for Cancer Research (CCR) SOP on Guidelines for Development and maintenance of Regulatory Files/Binders.

SCOPE:  The policy applies to all studies conducted or coordinated by the Center for Cancer Research
(CCR) Teams.

CONSIDERATIONS/REFERENCES/DEFINITIONS:  Federal Regulations require documentation of all
study-related activities. The regulatory files and subject records serve as documentation of a site’s
compliance with standards of Good Clinical Practice (GCP) and Federal regulations.

Definitions:

ICH/GCP Definitions:

REGULATIONS/GUIDELINES:

21 CFR:

FDA Bulletins:

RESPONSIBILITY:  The responsibility for maintaining a regulatory file/binder at the point of care is the
Principal Investigator’s. This task is usually delegated to members of the Research Team, including the
Research Nurse/Protocol Coordinator and Data Manager. Each branch/research unit must ensure that
the standard is met as defined.